摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(1,4-dioxaspiro[4.5]dec-8-ylmethyl)acetamide | 299180-11-3

中文名称
——
中文别名
——
英文名称
N-(1,4-dioxaspiro[4.5]dec-8-ylmethyl)acetamide
英文别名
N-(1,4-dioxaspiro[4.5]decan-8-ylmethyl)acetamide
N-(1,4-dioxaspiro[4.5]dec-8-ylmethyl)acetamide化学式
CAS
299180-11-3
化学式
C11H19NO3
mdl
——
分子量
213.277
InChiKey
XMNMVLBNESBOST-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.91
  • 拓扑面积:
    47.6
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-(1,4-dioxaspiro[4.5]dec-8-ylmethyl)acetamide氢氧化钾甲酸三乙胺 作用下, 以 乙醇甲苯 为溶剂, 反应 26.0h, 生成 (+/-)-N-[(2-acetyl-4,5,6,7-tetrahydro-2H-izoindol-5-yl)methyl]acetamide
    参考文献:
    名称:
    A general synthetic approach to novel conformationally restricted arginine side chain mimetics
    摘要:
    A general synthesis of several novel partially saturated, conformationally restricted heterobicyclic arginine side chain mimetics is described. These compounds are interesting peptidomimetic building blocks for incorporation into trypsin-like serine protease inhibitors. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4020(01)01243-1
  • 作为产物:
    描述:
    4-氰基环己酮缩乙二醇 在 lithium aluminium tetrahydride 作用下, 以 四氢呋喃 为溶剂, 反应 1.0h, 生成 N-(1,4-dioxaspiro[4.5]dec-8-ylmethyl)acetamide
    参考文献:
    名称:
    A general synthetic approach to novel conformationally restricted arginine side chain mimetics
    摘要:
    A general synthesis of several novel partially saturated, conformationally restricted heterobicyclic arginine side chain mimetics is described. These compounds are interesting peptidomimetic building blocks for incorporation into trypsin-like serine protease inhibitors. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4020(01)01243-1
点击查看最新优质反应信息

文献信息

  • Rhodium(III)-Catalyzed Anti-Markovnikov Hydroamidation of Unactivated Alkenes Using Dioxazolones as Amidating Reagents
    作者:Noah Wagner-Carlberg、Tomislav Rovis
    DOI:10.1021/jacs.2c10552
    日期:2022.12.14
    general method for the intermolecular anti-Markovnikov hydroamidation of unactivated alkenes under mild conditions, utilizing Rh(III) catalysis in conjunction with dioxazolone amidating reagents and isopropanol as an environmentally friendly hydride source. The reaction tolerates a wide range of functional groups and efficiently converts electron-deficient alkenes, styrenes, and 1,1-disubstituted alkenes
    酰胺是所有药物中最常见的官能团之一,因此,引入酰胺部分的反应具有特别的价值。烯烃的分子间加氢酰胺化仍然是一种尚未充分探索的合成含酰胺化合物的方法。大多数氢酰胺化过程表现出马尔可夫尼科夫区域选择性,而目前的反马尔可夫尼科夫氢酰胺化方法在某种程度上仅限于活化的烯烃底物或自由基过程。在此,我们报告了一种在温和条件下对未活化的烯烃进行分子间反马可夫尼科夫氢酰胺化的通用方法,利用Rh(III)催化结合二恶唑酮酰胺化试剂和异丙醇作为环境友好的氢化物源。该反应可耐受多种官能团,可有效地将缺电子烯烃、苯乙烯和 1,1-二取代烯烃以及未活化的烯烃转化为相应的直链酰胺。机理研究揭示了可逆的氢化铑迁移插入步骤,从而导致抗马可夫尼科夫产物具有精细的选择性。
  • A general synthesis of novel conformationally restricted arginine side-chain mimetics
    作者:Lucija P Mašič、Danijel Kikelj
    DOI:10.1016/s0040-4039(00)00869-8
    日期:2000.7
    6-(Aminomethyl)-5,6,7,8-tetrahydro-2-quinazolinamine and 4,5,6,7-tetrahydro-2H-indazol-5-ylmethanamine were synthesized as novel conformationally restricted arginine side-chain mimetics, designed for incorporation into trypsin-like serine protease inhibitors. (C) 2000 Elsevier Science Ltd. All rights reserved.
  • US7524871B2
    申请人:——
    公开号:US7524871B2
    公开(公告)日:2009-04-28
  • A general synthetic approach to novel conformationally restricted arginine side chain mimetics
    作者:Lucija Peterlin-Mašič、Andreja Jurca、Petra Marinko、Anita Jančar、Danijel Kikelj
    DOI:10.1016/s0040-4020(01)01243-1
    日期:2002.2
    A general synthesis of several novel partially saturated, conformationally restricted heterobicyclic arginine side chain mimetics is described. These compounds are interesting peptidomimetic building blocks for incorporation into trypsin-like serine protease inhibitors. (C) 2002 Elsevier Science Ltd. All rights reserved.
查看更多